pI: 8.9531 |
Length (AA): 362 |
MW (Da): 40152 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
10 | 356 | 4idc (A) | 3 | 318 | 23.00 | 0 | 1 | 1.04786 | 0.21 |
17 | 341 | 1zsy (A) | 20 | 345 | 37.00 | 0 | 1 | 1.38509 | -0.67 |
20 | 321 | 1gu7 (A) | 24 | 351 | 37.00 | 0 | 1 | 1.22555 | -0.51 |
31 | 109 | 1e3i (A) | 18 | 91 | 43.00 | 0.000039 | 0.55 | 0.592532 | 0.09 |
145 | 322 | 4oki (A) | 677 | 848 | 20.00 | 0.00000000015 | 1 | 0.820013 | -0.88 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127865)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G45770 | putative trans-2-enoyl-CoA reductase |
Brugia malayi | Bm1_31850 | oxidoreductase, zinc-binding dehydrogenase family protein |
Candida albicans | CaO19.5450 | one of two genes similar to C.tropicalis ETR1 (AAL55472) and ETR2 (AAL55471) fungal mitochondrial medium chain 2-enoyl thioester |
Candida albicans | CaO19.12905 | one of two genes similar to C.tropicalis ETR1 (AAL55472) and ETR2 (AAL55471) fungal mitochondrial medium chain 2-enoyl thioester |
Caenorhabditis elegans | CELE_W09H1.5 | Protein MECR-1 |
Caenorhabditis elegans | CELE_Y48A6B.9 | Protein Y48A6B.9, isoform B |
Dictyostelium discoideum | DDB_G0278095 | 2-enoyl thioester reductase |
Drosophila melanogaster | Dmel_CG16935 | CG16935 gene product from transcript CG16935-RA |
Echinococcus granulosus | EgrG_000727100 | mitochondrial trans 2 enoyl coenzyme A reductase |
Echinococcus multilocularis | EmuJ_000727100 | mitochondrial trans 2 enoyl coenzyme A reductase |
Homo sapiens | ENSG00000116353 | mitochondrial trans-2-enoyl-CoA reductase |
Leishmania braziliensis | LbrM.04.0330 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_040280.1 | Alcohol dehydrogenase GroES-like domain containing protein, putative |
Leishmania infantum | LinJ.04.0280 | hypothetical protein, conserved |
Leishmania major | LmjF.04.0290 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.04.0290 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09612 | hypothetical protein |
Mus musculus | ENSMUSG00000028910 | mitochondrial trans-2-enoyl-CoA reductase |
Mycobacterium ulcerans | MUL_2797 | quinone reductase, Qor |
Oryza sativa | 4351241 | Os12g0102100 |
Oryza sativa | 9271884 | Os11g0166201 |
Oryza sativa | 9272332 | Os11g0102500 |
Saccharomyces cerevisiae | YBR026C | Etr1p |
Schistosoma japonicum | Sjp_0029890 | ko:K07512 mitochondrial trans-2-enoyl-CoA reductase, putative |
Schistosoma japonicum | Sjp_0205300 | ko:K07512 mitochondrial trans-2-enoyl-CoA reductase, putative |
Schistosoma mansoni | Smp_026310 | zinc binding dehydrogenase |
Schmidtea mediterranea | mk4.014202.01 | Trans-2-enoyl-CoA reductase, mitochondrial |
Schmidtea mediterranea | mk4.014927.01 | Trans-2-enoyl-CoA reductase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.9.3870 | oxidoreductase, putative |
Trypanosoma brucei | Tb927.9.7190 | Trans-2-enoyl-ACP reductase 1, putative |
Trypanosoma congolense | TcIL3000_9_2430 | oxidoreductase, putative |
Trypanosoma cruzi | TcCLB.506627.20 | hypothetical protein, conserved |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.160.5260 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.160.5260 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.160.5260 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.160.5260 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.